Subject: RE: Defining a WHO process to validate elimination of viral hepatitis as a public threat, Geneva, Switzerland, 20-22 April 2020
From: "DOMENTE, Silviu" <[email-masked]>
To: Amiran Gamkrelidze <[email-masked]>, Tamar Gabunia <[email-masked]>
Date: Tue, 25 Feb 2020 16:45:05 +0000

Dear Dr. Amiran,

Thank you for the provided information about the selected nominee.

I forwarded the information to WHO HQ and they will contact Maia Tsereteli soon.

With best regards,

Silviu

From: Amiran Gamkrelidze <[email-masked]>

Sent: Tuesday, February 25, 2020 16:33

To: DOMENTE, Silviu <[email-masked]>; Tamar Gabunia <[email-masked]>

Subject: RE: Defining a WHO process to validate elimination of viral hepatitis as a public threat, Geneva, Switzerland, 20-22 April 2020

Dear Dr. Silviu,

Thank you for sending information regarding the upcoming WHO meeting for the establishment of elimination criteria for
the validation process of viral hepatitis elimination.

After conferring with the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social
Affairs of Georgia,  we are sending the name and the contact details of the nominee who was selected to participate in the meeting:

Maia Tsereteli, MD, Ph.D -  Head of Department of HIV/AIDS, Hepatitis, STI & TB, National Center for Disease Control and
Public Health ( Cell: 995 (599) 579074; E-mail:
[email-masked])

Please, let us know if you need any additional information.

Kind regards,

Amiran

Amiran Gamkrelidze, MD, PhD, Professor

National Center for Disease Control and Public Health

Director General

Tbilisi 0198, Kakheti Hwy. #99

Phone: +995 32 2192599

Email:
[email-masked]

www.ncdc.ge

From: DOMENTE, Silviu [mailto:[email-masked]]

Sent: Thursday, February 20, 2020 9:44 AM

To: Tamar Gabunia

Cc: Amiran Gamkrelidze

Subject: FW: Defining a WHO process to validate elimination of viral hepatitis as a public threat, Geneva, Switzerland, 20-22 April 2020

Importance: High

Dear Tamar,

Please find below and attached information about the WHO meeting for the establishment of elimination criteria for the validation process of viral hepatitis elimination.

Please note that only a limited number of countries are invited to the event (9 altogether) – only those that have achieved major progress towards elimination and priority countries with high disease burden.

We would appreciate the nomination of an expert from Georgia to attend the meeting, preferably by 29 February.

The meeting will be quite technical, focusing on measuring indicators and hepatitis elimination validation process. So, ideally the nominated person should be quite high level (e.g. Director of Department), but also very familiar with communicable
disease control, including hepatitis.

Please send your nomination to Dr Judih Van Holten at:
[email-masked] or to me directly and I will forward it.

All related travel expenses will be covered by WHO.

Thank you and best regards,

Silviu

From: SUCHET, Corinne C.p. On Behalf Of DOHERTY, Meg

Sent: Wednesday, February 19, 2020 21:50

To: DOMENTE, Silviu <[email-masked]>

Cc: EMIROGLU, Nedret <[email-masked]>; DARA, Masoud <[email-masked]>; SEGUY, Nicole Simone <[email-masked]>; MOZALEVSKIS, Antons <[email-masked]>;
VAN HOLTEN, Judith <[email-masked]>; BALL, Andrew Lee <[email-masked]>; KAWANGUZI, Lydia Mirembe <[email-masked]>; DOHERTY, Meg <[email-masked]>;
EURO WHO Office in Georgia <[email-masked]>

Subject: Defining a WHO process to validate elimination of viral hepatitis as a public threat, Geneva, Switzerland, 20-22 April 2020

Importance: High

Dear Dr Domente,

On behalf of Dr Meg Doherty, Director, Global HIV, Hepatitis and STIs Programme, please find attached a memorandum requesting the participation of the Ministry of
Labour, Health and Social Affairs to the above mentioned meeting.

Thank you very much for your attention.

Best regards,

Corinne

On behalf of

Meg Doherty, MD, PhD, MPH

Director

Global HIV, Hepatitis and STI Programme

World Health Organization | 20 Avenue Appia, Geneva, 1211 Switzerland

Tel: +41-22-791 3814| Mobile: +41-79-468 2803 | E-mail:
[email-masked]

Web:
http://www.who.int/hiv/en/ and
http://www.who.int/hepatitis/en/